V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280007495 | 280010320 | null | 52.4 | Curative (C) | 2016-05-21 | 2016-06-17 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | Y | 280024787 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007496 | 280011654 | 1.8 | null | Neo-adjuvant (N) | 2017-11-22 | 2017-12-07 | Cetuximab 7 day (Cycle 1) | 2 | N | 280024787 | CETUXIMAB |
| 280007497 | 280004770 | 0 | 80.9 | Curative (C) | 2016-09-11 | 2016-10-23 | Carboplatin AUC 2 - 5 | N | null | 280024793 | CARBOPLATIN |
| 280007498 | 280004770 | 1.79 | null | Neo-adjuvant (N) | 2014-04-15 | 2014-04-15 | Docetaxel + Gemcitabine with GCSF | N | N | 280024793 | DOCETAXEL + GEMCITABINE |
| 280007499 | 280010321 | 1.74 | null | Palliative (P) | 2016-02-19 | 2016-02-19 | Docetaxel+Gemcitabine (no prior RT) | 02 | N | 280024797 | DOCETAXEL + GEMCITABINE |
| 280007500 | 280004771 | null | null | Neo-adjuvant (N) | 2017-06-01 | 2017-06-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | null | 280024798 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007501 | 280008538 | 0 | 72 | Curative (C) | 2015-03-15 | 2015-10-26 | WT SIOP 2002 01 post op VAV | 2 | N | 280024801 | NOT MATCHED |
| 280007502 | 280004773 | 1.79 | 95.4 | Palliative (P) | 2015-12-02 | 2015-12-02 | Docetaxel + Gemcitabine (prior RT) | N | null | 280024802 | DOCETAXEL + GEMCITABINE |
| 280007503 | 280004774 | null | 74 | Neo-adjuvant (N) | null | 2014-02-02 | Olaratumab | null | null | 280024803 | NOT MATCHED |
| 280007504 | 280004777 | 1.8 | null | Palliative (P) | 2017-04-09 | 2017-04-17 | Cetuximab 7 day (>Cycle 2) | N | N | 280024804 | CETUXIMAB |
| 280007505 | 280004780 | 1.7 | 15.9 | Curative (C) | 2014-04-05 | 2014-04-16 | CARBOPLATIN | 02 | N | 280024810 | CARBOPLATIN |
| 280007506 | 280004780 | 1.67 | 63.3 | Curative (C) | 2016-02-10 | 2016-03-16 | CETUXIMAB | N | N | 280024810 | CETUXIMAB |
| 280007507 | 280004781 | 1.8 | null | Neo-adjuvant (N) | 2017-06-28 | 2017-08-01 | STS Rhabdomyosarco RMS 2005 IVADoVV | N | N | 280024815 | NOT MATCHED |
| 280007508 | 280004783 | 1.79 | 128.8 | Curative (C) | 2014-02-10 | 2015-01-03 | STS Rhabdomyosarco RMS 2005 IVADoVV | 02 | null | 280024817 | NOT MATCHED |
| 280007509 | 280004784 | 0 | 75.75 | Neo-adjuvant (N) | 2016-12-24 | 2016-12-25 | EW EuroEwing 2012 Arm A VAC | 2 | N | 280024821 | NOT MATCHED |
| 280007510 | 280004790 | 1.6 | 41.6 | Curative (C) | 2015-11-13 | 2015-12-11 | Cetuximab 7 day (>Cycle 2) | 02 | N | 280024823 | CETUXIMAB |
| 280007511 | 280004791 | 1.71 | null | Neo-adjuvant (N) | 2017-08-09 | 2017-08-30 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 280024825 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007512 | 280004792 | 1.76 | 67.7 | Curative (C) | 2015-06-30 | 2015-08-22 | Carboplatin AUC 6 - 10 | 02 | N | 280024825 | CARBOPLATIN |
| 280007513 | 280004792 | null | null | Palliative (P) | 2014-03-26 | 2014-03-26 | Carboplatin AUC 6 - 10 | N | N | 280024825 | CARBOPLATIN |
| 280007514 | 280004793 | null | 88 | Curative (C) | 2018-01-25 | 2018-02-15 | CISPLATIN + DOCETAXEL + FLUOROURACIL | Y | N | 280024836 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007515 | 280004796 | null | null | Neo-adjuvant (N) | 2015-12-13 | 2015-12-27 | Carboplatin AUC 6 - 10 | 2 | N | 280024848 | CARBOPLATIN |
| 280007516 | 280008545 | 0 | 9.4 | Curative (C) | 2015-11-18 | 2015-11-29 | Carboplatin AUC 6 - 10 | 02 | N | 280024851 | CARBOPLATIN |
| 280007517 | 280004798 | 1.78 | 81.2 | Curative (C) | 2016-08-08 | 2016-08-16 | Carboplatin AUC 2 - 5 | 2 | N | 280024854 | CARBOPLATIN |
| 280007518 | 280008547 | null | 54.7 | null | 2013-04-16 | 2013-05-11 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 01 | N | 280024855 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007519 | 280004799 | 1.72 | 76 | null | 2016-05-16 | 2016-05-31 | Cetuximab 7 day (>Cycle 2) | N | N | 280024855 | CETUXIMAB |
| 280007520 | 280004800 | null | 89 | Curative (C) | 2018-11-06 | 2019-01-06 | CARBOPLATIN | 2 | N | 280024861 | CARBOPLATIN |
| 280007521 | 280008549 | 0 | 55.9 | Neo-adjuvant (N) | 2012-08-22 | 2013-04-03 | STS Rhabdo RMS 2005 | 02 | N | 280024862 | NOT MATCHED |
| 280007522 | 280004802 | null | 52 | null | 2015-12-06 | 2015-12-08 | NB HRNBL-1 COJEC Ind COURSE B | N | N | 280024866 | NOT MATCHED |
| 280007523 | 280004806 | null | 92.7 | Neo-adjuvant (N) | 2013-08-02 | 2013-08-21 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280024870 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007524 | 280004808 | 1.64 | null | Neo-adjuvant (N) | null | 2017-12-05 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024875 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007525 | 280004809 | null | 111.85 | Palliative (P) | 2013-03-25 | 2013-05-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 01 | N | 280024875 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007526 | 280004809 | 1.87 | 89.5 | Adjuvant (A) | null | 2013-07-21 | DOCETAXEL + GEMCITABINE | N | Y | 280024875 | DOCETAXEL + GEMCITABINE |
| 280007527 | 280004810 | 1.78 | 59.6 | Curative (C) | 2017-12-19 | 2018-02-03 | Carboplatin AUC 6 - 10 | null | null | 280024882 | CARBOPLATIN |
| 280007528 | 280004811 | 0 | 95.4 | Curative (C) | 2014-10-07 | 2014-11-18 | STS Rhabdomyosarco RMS 2005 IVADoVV | null | null | 280024884 | NOT MATCHED |
| 280007529 | 280004812 | 0 | null | Neo-adjuvant (N) | 2013-12-13 | 2014-03-19 | EW EuroEwing 2012 Arm B VC | 02 | N | 280024885 | NOT MATCHED |
| 280007530 | 280004814 | 1.78 | 66.6 | Palliative (P) | 2016-11-08 | 2017-01-30 | Cetuximab 7 day (>Cycle 2) | N | null | 280024885 | CETUXIMAB |
| 280007531 | 280008554 | null | 60.2 | Neo-adjuvant (N) | null | 2018-03-13 | CISPLATIN + DOCETAXEL + FLUOROURACIL | null | N | 280024888 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007532 | 280008554 | 0 | 97 | Neo-adjuvant (N) | 2017-08-01 | 2017-08-02 | Olaratumab | 02 | N | 280024888 | NOT MATCHED |
| 280007533 | 280011212 | null | 4.6 | Neo-adjuvant (N) | 2015-04-01 | 2015-05-20 | Cisplatin + Docetaxel +Fluorouracil | null | null | 280024889 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007534 | 280004820 | null | null | Neo-adjuvant (N) | 2016-03-10 | 2016-09-18 | EW EuroEwing 2012 Arm B VC | 02 | null | 280024895 | NOT MATCHED |
| 280007535 | 280008555 | 1.85 | 76 | Curative (C) | 2017-08-07 | 2017-09-16 | Carboplatin AUC 6 - 10 | N | N | 280024896 | CARBOPLATIN |
| 280007536 | 280008556 | 1.63 | 63.3 | null | 2014-04-17 | 2014-05-15 | Cetuximab 7 day (Cycle 1) | 02 | N | 280024896 | CETUXIMAB |
| 280007537 | 280004826 | null | 94.4 | Neo-adjuvant (N) | 2016-01-28 | 2016-03-15 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280024903 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280007538 | 280004828 | 1.75 | 102.8 | null | 2016-01-30 | 2017-07-06 | null | Y | N | 280024907 | NOT MATCHED |
| 280007539 | 280004829 | 0 | 10.8 | Neo-adjuvant (N) | 2015-09-20 | 2015-09-25 | Olaratumab | 02 | N | 280024913 | NOT MATCHED |
| 280007540 | 280008560 | 1.86 | 19.3 | Neo-adjuvant (N) | 2016-06-06 | 2016-06-26 | Docetaxel+Gemcitabine (no prior RT) | null | N | 280024913 | DOCETAXEL + GEMCITABINE |
| 280007541 | 280008561 | 1 | null | Neo-adjuvant (N) | 2016-06-03 | 2016-06-03 | STS Rhabdomyosarcoma RMS 2005 IVAVV | 02 | N | 280024915 | NOT MATCHED |
| 280007542 | 280004831 | 1.67 | null | Curative (C) | 2015-11-20 | 2015-11-27 | CETUXIMAB | N | Y | 280024916 | CETUXIMAB |
| 280007543 | 280008562 | 1.08 | null | Curative (C) | 2015-07-07 | 2016-02-22 | STS Rhabdo VIT0910 Vinc Irino Temoz | N | Y | 280024918 | NOT MATCHED |
| 280007544 | 280004833 | 1.57 | 82 | Neo-adjuvant (N) | 2015-12-04 | 2016-05-30 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280024920 | DOCETAXEL + GEMCITABINE |